| William Boyan, MD | |
|
7068 Wing Point Rd Ne, Bainbridge Island, WA 98110-2987 | |
| (206) 335-0934 | |
| Not Available |
| Full Name | William Boyan |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 29 Years |
| Location | 7068 Wing Point Rd Ne, Bainbridge Island, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124119144 | NPI | - | NPPES |
| 8430514 | Medicaid | WA | |
| 1050BO | Other | WA | BSWA |
| 0214447 | Other | WA | LIWA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MD00044635 (Washington) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0101058258 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Peter Hospital | Olympia, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 6709782600 | 393 |
News Archive
Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.
Scientists studying hatchling fish have made a new advance in studying a chemical in the brain that impacts on movement.
The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research last week launched a Phase 2 clinical trial in Thailand to evaluate an interleukin-15 (IL-15) superagonist, ImmunityBio's Anktiva (also called N-803), administered during acute HIV infection as an experimental therapy to target establishment of the HIV reservoir at a very early stage.
With a recent two-year, $833,000 grant from the U.S. Department of Defense, kinesiology professor Richard van Emmerik and colleagues at the University of Massachusetts Amherst hope to eventually help an estimated 1 million people worldwide living with progressive multiple sclerosis (MS) by creating an improved diagnostic test for this form of the disease, which is characterized by a steady decrease in nervous system function.
Previous studies have shown that proliferation of endogenous neural precursor cells cannot alone compensate for the damage to neurons and axons. From the perspective of neural plasticity, Dr. Yun Xiang and co-workers from Sun Yat-sen University in China observed the effects of functional electrical stimulation treatment on endogenous neural precursor cell proliferation and expression of basic fibroblast growth factor and epidermal growth factor in the rat brain on the infarct side.
› Verified 5 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.
Scientists studying hatchling fish have made a new advance in studying a chemical in the brain that impacts on movement.
The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research last week launched a Phase 2 clinical trial in Thailand to evaluate an interleukin-15 (IL-15) superagonist, ImmunityBio's Anktiva (also called N-803), administered during acute HIV infection as an experimental therapy to target establishment of the HIV reservoir at a very early stage.
With a recent two-year, $833,000 grant from the U.S. Department of Defense, kinesiology professor Richard van Emmerik and colleagues at the University of Massachusetts Amherst hope to eventually help an estimated 1 million people worldwide living with progressive multiple sclerosis (MS) by creating an improved diagnostic test for this form of the disease, which is characterized by a steady decrease in nervous system function.
Previous studies have shown that proliferation of endogenous neural precursor cells cannot alone compensate for the damage to neurons and axons. From the perspective of neural plasticity, Dr. Yun Xiang and co-workers from Sun Yat-sen University in China observed the effects of functional electrical stimulation treatment on endogenous neural precursor cell proliferation and expression of basic fibroblast growth factor and epidermal growth factor in the rat brain on the infarct side.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Boyan, MD 7068 Wing Point Rd Ne, Bainbridge Island, WA 98110-2987 Ph: () - | William Boyan, MD 7068 Wing Point Rd Ne, Bainbridge Island, WA 98110-2987 Ph: (206) 335-0934 |
News Archive
Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.
Scientists studying hatchling fish have made a new advance in studying a chemical in the brain that impacts on movement.
The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research last week launched a Phase 2 clinical trial in Thailand to evaluate an interleukin-15 (IL-15) superagonist, ImmunityBio's Anktiva (also called N-803), administered during acute HIV infection as an experimental therapy to target establishment of the HIV reservoir at a very early stage.
With a recent two-year, $833,000 grant from the U.S. Department of Defense, kinesiology professor Richard van Emmerik and colleagues at the University of Massachusetts Amherst hope to eventually help an estimated 1 million people worldwide living with progressive multiple sclerosis (MS) by creating an improved diagnostic test for this form of the disease, which is characterized by a steady decrease in nervous system function.
Previous studies have shown that proliferation of endogenous neural precursor cells cannot alone compensate for the damage to neurons and axons. From the perspective of neural plasticity, Dr. Yun Xiang and co-workers from Sun Yat-sen University in China observed the effects of functional electrical stimulation treatment on endogenous neural precursor cell proliferation and expression of basic fibroblast growth factor and epidermal growth factor in the rat brain on the infarct side.
› Verified 5 days ago
Farshid Firoozbakht, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 945 Hildebrand Ln Ne, Ste 100, Bainbridge Island, WA 98110 Phone: 206-991-2121 Fax: 206-991-2151 | |
Dr. Wayne Russell Godfrey, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4927 Ne Tolo Rd, Bainbridge Island, WA 98110 Phone: 650-521-2770 | |
Dr. Donald Edward Stevens, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 945 Hildebrand Ln Ne, Suite 100, Bainbridge Island, WA 98110 Phone: 206-991-2121 Fax: 206-991-2151 | |
Bruce E Gottlieb, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1344 Wintergreen Ln Ne, Bainbridge Island, WA 98110 Phone: 206-842-5632 | |
Mr. Hai Tran, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1344 Wintergreen Ln Ne Unit 200, Bainbridge Island, WA 98110 Phone: 206-855-7600 Fax: 206-855-7697 | |
Dr. Jennifer Ann Newman, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8804 Madison Ave Ne, Suite 200, Bainbridge Island, WA 98110 Phone: 206-855-7600 Fax: 206-855-7698 |